Emerging Infectious Disease ISSN: 1080-6059

Plasmodium vivax Malaria

Dhanpat K. Kochar*

, Vishal Saxena†, Narvachan Singh*, Sanjay K. Kochar*, S. Vijay Kumar†, and Ashis Das†

Author affiliations: *Sardar Patel Medical College, Bikaner, Rajasthan, India; †Birla Institute of Technology and Science, Pilani, Rajasthan, India

Main Article

Figure

Polymerase chain reaction analysis of patient samples: lane Pf = positive control showing P. falciparum band at position ≈1400 bp; lanes 1–7 and 9–12 = P. vivax– positive samples showing band at ≈500 bp; (lanes 1–7 correspond to cases 1–7, and lanes 9–12 correspond to patients 8–11 numbered in Tables 1 and 2.); lane 8 = sample showing bands at ≈1,400 bp and 500 bp, indicating mixed infection; lane 13 = negative control, normal human DNA; lane M = 1-kb DNA ladder mix (MBI Fermentas, SM#033)

Figure. Polymerase chain reaction analysis of patient samples: lane Pf = positive control showing P. falciparum band at position ≈1400 bp; lanes 1–7 and 9–12 = P. vivax– positive samples showing band at ≈500 bp; (lanes 1–7 correspond to cases 1–7, and lanes 9–12 correspond to patients 8–11 numbered in Tables 1 and 2.); lane 8 = sample showing bands at ≈1,400 bp and 500 bp, indicating mixed infection; lane 13 = negative control, normal human DNA; lane M = 1-kb DNA ladder mix (MBI Fermentas, SM#033)

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.